Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 3Anxiety Disorders 3Pain 2Gastrointestinal Neoplasms 2Depression 2Acute Pain 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Otolaryngeal Cancer 1Mucositis 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Colorectal Neoplasms 1Cancer: Breakthrough Pain 1Agnosia 1

Interventions

Oxaliplatin 3Irinotecan 3Surveys and Questionnaires 2Specimen Handling 2Radiosurgery 2Leucovorin 2Ketamine 2Hydroxychloroquine 2Fluorouracil 2Capecitabine 2ulixertinib 1tegafur-gimeracil-oteracil 1regorafenib 1pazopanib 1lanreotide 1fludarabine phosphate 1fludarabine 1dostarlimab 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1danvatirsen 1cobimetinib 1brivanib 1auricularum 1atezolizumab 1alectinib 1aldesleukin 1abelacimab 1Tomography, X-Ray Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Gastrointestinal Neoplasms × Ketamine × Clear all
NCT06077487 2025-05-21

Ketamine-assisted Therapy for Advanced GI Cancer

University of California, San Francisco

Phase 4 Terminated
1 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms, Acute Pain

NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡